HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Praus Selected Research

Angiogenesis Inhibitors

2/2001The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Praus Research Topics

Disease

1Neoplasms (Cancer)
02/2001

Drug/Important Bio-Agent (IBA)

1FibrinolysinFDA Link
02/2001
1Peptide Hydrolases (Proteases)FDA Link
02/2001
1PlasminogenIBA
02/2001
1Plasminogen Activators (Plasminogen Activator)IBA
02/2001
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
02/2001
1Plasminogen InactivatorsIBA
02/2001
1Plasminogen Activator Inhibitor 1IBA
02/2001
1VitronectinIBA
02/2001
1Angiogenesis InhibitorsIBA
02/2001